Scaled Cognition Raises $100M to Eliminate AI Hallucinations
Khosla Ventures leads Series A for startup building hallucination-free AI models targeting healthcare and other critical applications.
AI Lab Targets Reliability Crisis With Nine-Figure Raise
Scaled Cognition has closed a $100 million Series A funding round led by Khosla Ventures to address one of artificial intelligence's most persistent problems: hallucinations that produce false or fabricated information.
CEO Dan Roth and Khosla Ventures founder Vinod Khosla discussed the funding and the company's mission during an appearance on Fox Business's "The Claman Countdown," emphasizing the critical need for accuracy in AI systems as they move into high-stakes applications.
The Hallucination Problem
AI hallucinations—instances where models generate plausible-sounding but incorrect information—have created real-world consequences for organizations deploying the technology. Roth and Khosla cited examples including Air Canada, which was held liable for misinformation provided by its chatbot, and errors from Google's Bard system that damaged credibility during its public launch.
These failures underscore a fundamental challenge: as AI systems are integrated into customer service, research, and decision-making workflows, the cost of unreliable outputs escalates dramatically.
Why it matters
For enterprise leaders evaluating AI deployments, hallucinations represent both a liability risk and a barrier to adoption in regulated industries. Scaled Cognition's focus on eliminating false outputs rather than simply improving average accuracy could unlock AI applications in healthcare, legal, and financial services where errors carry serious consequences. The substantial Series A signals investor confidence that reliability—not just capability—will differentiate next-generation AI platforms.
APT-1 Model Targets Critical Applications
Scaled Cognition is developing its APT-1 model with the goal of achieving hallucination-free performance. The company is particularly focused on healthcare applications, where incorrect AI-generated information could directly impact patient safety and clinical decisions.
The $100 million round positions the AI lab to compete in a market where reliability has become as important as raw performance metrics. While many AI companies tout improved benchmarks and expanded capabilities, Scaled Cognition is betting that enterprises will pay a premium for systems they can trust in mission-critical contexts.
Khosla Ventures' leadership of the round brings both capital and strategic guidance from one of Silicon Valley's most prominent AI investors. Vinod Khosla has backed numerous AI companies and has been vocal about the technology's potential to transform industries when deployed responsibly.
The funding details were first reported by Fox Business during the June 25 broadcast.
This is an original analysis by the Omega editorial team. Source reporting: AI Watch.
Want systems like this working for your business?
Book a Call
